ARGX

argenx
D

ARGX

Arincen71/100B

argenx EPS (earnings per share) 2011–2026

argenx's diluted EPS in H2 FY2026, the six months to 30 September 2026, was 7.80 USD, with no change to compare on the same half a year before. argenx's diluted earnings per share over the last twelve months were 20.82 USD, up 6.3% on the twelve months before. In fiscal year 2025 they were 19.63 USD, up 53.6% on the year before.

Last updated 7 Nov 2026 · Next report 25 Feb 2027

EPS

Growth

Fiscal yearPeriod endingEPSGrowthEPS (basic)
TTM30 Sept 202620.82+6.28%21.56
FY202531 Dec 202519.63+53.60%21.14
FY202431 Dec 202412.78—13.92
FY202331 Dec 2023-5.16—-5.16
FY202231 Dec 2022-13.05—-13.05
FY202131 Dec 2021-7.99—-7.99
FY202031 Dec 2020-13.40—-13.40
FY201931 Dec 2019-4.69—-4.69
FY201831 Dec 2018-2.12—-2.12
FY201731 Dec 2017-1.37—-1.37
FY201631 Dec 2016-1.20—-1.19
FY201531 Dec 2015-1.06—-1.06
FY201431 Dec 2014-0.80—-0.80
FY201331 Dec 2013-0.54—-0.54
FY201231 Dec 2012-0.82—-0.82
FY201131 Dec 2011-0.29—-0.29

Figures in USD. Shares and EPS are adjusted for stock splits. Quarterly growth is on the same quarter a year before; TTM is the last four quarters.

See also:Revenue,Net income,Shares outstanding,Operating income,Cash on hand,Total debt,Free cash flow,Income statement

Common questions about argenx's EPS

Source: Financial Modeling Prep

Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Never invest money you cannot afford to lose, and carefully assess the suitability of complex products such as CFDs and derivatives in light of your financial situation. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes.

Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

© 2026 - Arincen L.L.C-FZ - License No. 2420098.01. All Rights Reserved.